AwardedItalyGoods€2,233,980
ESECUZIONE E REFERTAZIONE TEST DI PROFILAZIONE GENOMICA PER PAZIENTI AFFETTE DA CARCINOMA INVASIVO DELLA MAMMELLA DI TIPO LUMINALE HER2-NEGATIVO IN FASE INIZIALE
- Published
- Published 10 February 2025
- Deadline
- Closed 17 March 2025
Overview
ESECUZIONE E REFERTAZIONE TEST DI PROFILAZIONE GENOMICA PER PAZIENTI AFFETTE DA CARCINOMA INVASIVO DELLA MAMMELLA DI TIPO LUMINALE HER2-NEGATIVO IN FASE INIZIALE
Key details
- Country
- Italy
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,233,980
- Procedure
- Open
- Published
- 10 February 2025
- Deadline
- Closed
Diagnostic systems
Award outcome
- Awarded value
- €819,000
- Award date
- 19 May 2025
- Contract period
- 19 May 2025 → 3 May 2028
- Genomic Health, Inc. Sede Secondaria n. MI/1
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 June 2025
Contract Notice
10 February 2025
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.